drugset / Trial / NCT04613024

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

NCT04613024

Phase 0 Withdrawn Stanford University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effects of topiramate (TPM) in obese patients with respect to weight loss and pain after total joint replacement surgery

Timeline

Start
2025-07-01
Primary completion
2025-12-01
Completion
2027-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule
Subject Topiramate Small molecule

Indications

No indication recorded.